Skip to content

Study · Ex vivo tissue · rat · 1987

3 results

Delta sleep inducing peptide inhibits somatostatin release via a dopaminergic mechanism.

Iyer KS, McCann SM

Neuroendocrinology1 Jun 1987Cited by 9 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueEfficacy outcome

    In rat median eminence incubated in vitro, DSIP inhibited somatostatin release in a dose-dependent manner.

    In plain wordsIn rat brain tissue in a dish, DSIP reduced the release of somatostatin as the dose rose.

    Outcome
    DecreaseSomatostatin release from median eminence
    Study

    ratn: not reported in source

    Rat median eminence, in vitro incubation
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    DSIP inhibited SRIF release in a dose-dependent manner.
    1 context sentence
    Summary · context
    The effect of DSIP on somatostatin (SRIF) release from the median eminence of the hypothalamus was evaluated in male and female rats in an in vitro incubation system.
  2. 02LabEx vivo tissueEfficacy outcome

    In rat median eminence in vitro, DSIP inhibited somatostatin release in both sexes, with less sensitivity in females than in males and maximum effect at 10(-8) M.

    In plain wordsIn rat brain tissue in a dish, DSIP reduced somatostatin release in both sexes, but less in females.

    Outcome
    DecreaseSex difference in DSIP inhibition of somatostatin release
    Study

    ratn: not reported in source

    Rat median eminence, in vitro incubation
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The median eminences from females were less sensitive to the inhibitory action of DSIP than those of males; however, in both sexes the maximum effect was observed at a concentration of 10(-8) M DSIP.
    1 context sentence
    Summary · context
    The effect of DSIP on somatostatin (SRIF) release from the median eminence of the hypothalamus was evaluated in male and female rats in an in vitro incubation system.
  3. 03LabEx vivo tissueMechanism

    In rat median eminence in vitro, pimozide at 10(-6) M blocked the inhibition of somatostatin release by DSIP.

    In plain wordsIn rat brain tissue in a dish, a dopamine blocker stopped the DSIP-driven drop in somatostatin release.

    Outcome
    Not applicablePimozide blockade of DSIP effect on somatostatin release
    Study

    ratn: not reported in source

    Rat median eminence, in vitro incubation
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    This effect was blocked by addition of pimozide at a concentration of 10(-6) M.
    1 context sentence
    Summary · context
    The effect of DSIP on somatostatin (SRIF) release from the median eminence of the hypothalamus was evaluated in male and female rats in an in vitro incubation system.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.